Navigation Links
Wireless Pill Bottle Wins Healthcare Innovation World Cup

NEW YORK, May 16, 2013 /PRNewswire/ -- Developers of a pill bottle that wirelessly transmits data, measures medication and sends patient reminders have emerged as grand prize winners in the Healthcare Innovation World Cup, the international diabetes innovation challenge funded by Boehringer Ingelheim and organized by HITLAB.

Winning team members Josh Stein , John Langhauser and Mike Morena of Team AdhereTech from the United States will receive $50,000 in prize money. They earned the top spot by demonstrating the exceptional impact, innovation, feasibility and financial sustainability of their idea, and for engaging with community members via social media.

AdhereTech received its honors at the Healthcare Innovation World Cup finals event on Friday, May 10 at the German Center for Research and Innovation in New York City. Judges selected Team IITKgp for second place, Team SmartSense for third place, and Team EndoGoal as the fourth-place finalist.

First-place AdhereTech has created wireless pill bottles to help improve medication adherence. According to AdhereTech, the bottles measure the exact number of pills in the bottle in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via automated phone call or text message. The devices also record and send adherence data with an unprecedented level of granularity. This summer, AdhereTech, which is based in New York, NY, will begin a trial with The Walter Reed Army Medical Center to test its full-service solution for type 2 diabetes patients. According to Josh Stein , CEO of AdhereTech, there are both issued patents and patents pending for the devices. The company has secured funding, and is actively seeking additional investors. Visit for more information.

"We are impressed with AdhereTech's prototype and the feasibility of their business model, and believe the solution has merit in supporting medication adherence," said Klaus Wilgenbus, SVP, PM business development and licensing strategy at Boehringer Ingelheim and Healthcare Innovation World Cup judge. "All of the finalists demonstrated outstanding quality and ingenuity in developing their solutions. It is evident that they are committed to creating innovations with the potential to make a real difference in the lives of people with diabetes and their families."

The three other finalists were:

  • Team IITKgp, second place winners of $10,000; members Praful P. Pai , Pradyut Kumar Sanki , Satyabrata Sarangi . Team IITKgp is developing a non-invasive blood glucose measurement device, based on photoacoustic spectroscopy, to enable painless, sample-free and accurate glucose measurement for diabetics. Initial measurements performed on tissue have provided an accuracy of nearly 70% compared to reference measurements. The team is working to improve this accuracy and developing a portable prototype device for wide-scale use and commercialization. IITKgp operates from the Department of Electronics & Electrical Communication Engineering on the campus of the Indian Institute of Technology Kharagpur.

  • Team SmartSense, third place winners of $5,000; members Dr. Mayur M. Sadawana , Dr. Rohit Srivastava , and Dr. Yogesh Patil . SmartSense is a multianalyte sensing device for diabetic ketoacidosis (DKA). It is being developed to sense all the metabolites necessary for management of the condition with a single prick. According to team members, it is designed to reduce the pain and economic burden faced by patients with DKA. The developing team of SmartSense is based at the Indian Institute of Technology Bombay.

  • Team EndoGoal; members Dr. Jennifer Shine Dyer (Twitter's @EndoGoddess), and Jeff Harper , DuetHealth. EndoGoal is a mobile and web-based rewards program for people with insulin-dependent diabetes who track daily glucoses. Rewards include weekly prepaid visa cards and a virtual pet, and are based on a social business model. Revenue comes from users' family-and-friend 'sponsors.' For more information about the Columbus, Ohio-based initiative, visit

"Considering the caliber of these finalists – as well as many other participants in this competition – the future of diabetes innovation is exceptionally bright. We anticipate big achievements for all four finalists, and are excited to follow their trajectories in the healthcare industry," said Cole Manship , director of the Healthcare Innovation World Cup and manager of new programs and initiatives at HITLAB. "We hope this competition serves as a solid platform for their ongoing success."

All four teams received $2,500 each for reaching the final round of the competition. Overall, more than 100 teams representing 20 countries around the globe submitted diabetes innovations for the Healthcare Innovation World Cup, which awarded a total $75,000 in prizes to semifinalists and finalists. For more information about the competition and judges, visit

About the Healthcare Innovation World Cup

The Healthcare Innovation World Cup challenges entrepreneurs and innovators in healthcare and information technology to tackle global public health issues. In 2013, the competition invited participants worldwide to propose solutions for improving diabetes prevention and management, offering $75,000 in total prize money and opportunities to showcase their work.


HITLAB is a cross-disciplinary public health teaching and research organization that studies and educates others about the impact of healthcare information and communications technology on public health. Based in New York, NY, the Lab's team includes faculty, scientists, research scholars and students from top universities around the world.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.

In 2012, Boehringer Ingelheim achieved net sales of about 14.7 billion euro. R&D expenditure in the business area Prescription Medicines corresponds to 22.5% of its net sales.

For more information please visit

About the German Center for Research and Innovation

The German Center for Research and Innovation provides information and support for the realization of cooperative and collaborative projects between North America and Germany. With the goal of enhancing communication on the critical challenges of the 21st century, GCRI hosts a wide range of events from lectures and exhibitions to workshops and science dinners. Opened in February 2010, GCRI was created as a cornerstone of the German government's initiative to internationalize science and research and is one of five centers worldwide.

Media Contacts:
Annie Alley
+1 (212) 543-0100

Arnd Prilipp
Boehringer Ingelheim GmbH
+49 (6132) 77-2091

SOURCE HITLAB; Boehringer Ingelheim GmbH
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
2. Polar Releases H7, a Preeminent Wireless Heart Rate Sensor with Bluetooth Smart
3. New Wireless Keyboard Rechargeable, Washable for Healthcare Applications
4. Patient Monitoring Devices Market to 2017 - Increasing Use of Wireless Remote Patient Monitoring to be the Key Technology Trend
5. World Renowned Inventor, Donald Spector, Develops Patent For Wireless Electric Acupuncture Patches
6. Remote and Wireless Patient Monitoring Markets
7. NYU and NYU-Poly Launch Worlds First Academic Research Center to Combine Medicine with Wireless Communications and Computing
8. FUJIFILM Introduces U.S.As First 24x30cm Wireless Detector At AHRA
9. MD+DI Announces Wireless Connectivity in Medical Devices EAST Conference in Boston, MA
10. Varian Medical Systems to Exhibit New Wireless Flat Panel Detector, Image Processing Software and X-Ray Tubes for Digital Radiography at RSNA
11. BlipCare Launches The Next Generation Wireless Weight Scale That Reminds Users To Take Their Readings
Post Your Comments:
(Date:10/8/2015)... Oct. 8, 2015  Clariant, a world leader in specialty ... facility in Belen, New Mexico , has ... including desiccant canisters and packets and other ... plant is the second Clariant site – the first in ... the ISO 15378:2011 standards, following only the Clariant manufacturing facility ...
(Date:10/8/2015)... , Oct. 8, 2015  Nektar Therapeutics (Nasdaq: ... pain and oncology portfolio during an Investor and Analyst ... p.m. Eastern Time in New York City ... of the NKTR-214 Phase 1/2 clinical program and biomarker ... cytokine designed to preferentially stimulate the production of CD8-positive ...
(Date:10/8/2015)... a clinical stage drug development company focused on advancing ... today the commencement of the US arm of an ... acebilustat, in patients with cystic fibrosis (CF). The study ... the United States and European Union, ... 2016. This landmark clinical trial testing once-daily oral acebilustat ...
Breaking Medicine Technology:
... Texas, Dec. 2, 2010 Ascension Orthopedics, Inc., ... another implantation of the TITAN™ Modular Total Shoulder. ... at Bucks County Specialty Hospital in Bensalem, Pennsylvania. ... postoperative x-rays showed a very anatomic replacement.  The ...
... 2, 2010 Medical devices, biotechnology and IT products ... will present to United States investors and the business ... business and investment opportunities. (Logo: ... successful Chilean Small and Medium Enterprises (SMEs) was selected ...
Cached Medicine Technology:
(Date:10/10/2015)... York, NY (PRWEB) , ... October 10, 2015 , ... ... some alarming numbers on the growth of cybercrime costs for US companies. The New ... on Tuesday, October 6th. With averages showing increases hovering around 20% among the companies ...
(Date:10/10/2015)... , ... October 10, 2015 , ... Isabel Healthcare will ... , On the heels of the release of the Institute of Medicine’s latest report ... their integration with Cerner solutions that assist healthcare providers and consumers to potentially reduce ...
(Date:10/9/2015)... ... October 09, 2015 , ... The American Osteopathic ... for Graduate Medical Education J. Michael Finley, DO, as the recipient of the ... for his impact on graduate medical education opportunities for osteopathic residents, and his ...
(Date:10/9/2015)... ... 2015 , ... A new health tool that helps identify if a sore ... ) – just in time for the cold and flu season, which the ... many in the U.S., the real start of cold/flu season is the start of ...
(Date:10/9/2015)... ... October 09, 2015 , ... Dentist in Huntington ... orthodontic system that uses clear, plastic aligners. This alternative to braces has become ... which allow patients to complete treatment in privacy. Additionally, Invisalign aligners are removable, ...
Breaking Medicine News(10 mins):
... serious problem that can often be fatal. Methadone has ... addicts. However, the major concern in treating heroin addicts ... is one reason methadone therapy is usually only given ... that an alternative drug therapy combined with psychosocial treatment ...
... researchers are currently testing the safety of hypothermia ... injury. Hypothermia treatment has been shown to be ... but its effectiveness in treating children with traumatic ... decreases inflammation, excitotoxicity (excessive neurotransmitters released with injury ...
... of skin cancer and it has been shown through previous ... sunlight, whose UV rays cause damage to DNA that triggers ... are more prone than others to melanoma. Researchers have now ... people with melanoma that those with fair skin// have lowered ...
... Affective Disorder(SAD) is not all that well understood, but ... sunlight in the winter months. Winter depression involves suffering ... days get longer and nights get shorter. Other SAD ... sleeping for longer than usual. Researchers have now found ...
... hospital in Kolkatta, India recently received a patient, a two-month-old ... suffering from a rare disease caused due to a deficiency ... of 10 million children. Doctors said that the baby was ... On detection the baby, a boy child, was found to ...
... time to its ultraviolet rays, has always been said to be ... shown that even moderate sun exposure can result in moles that ... to sun has been shown as the main risk factor for ... rarest type of skin cancer, is much weaker. It has however, ...
Cached Medicine News:
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: